Evaluation of Some Puberty-related Hormones Among Children and Adolescents With Chronic Kidney Diseases
NCT05835089 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2023-04-28
Summary
Puberty is the process of transition from childhood into adolescence, signaling the readiness of the human body for reproduction. The Hypothalamic-Pituitary Gonadotropin axis plays the primary role in initiating the puberty, where the hypothalamus secrets gonadotropin releasing hormone (GnRH) in a pulsatile manner, which in turn stimulates the release of luteinizing hormone (LH), and follicle stimulating hormone (FSH) from the anterior lobe of the pituitary gland, and in a final step these hormones stimulate the gonads to release their sex hormones (Testosterone and Estradiol) .
Chronic illnesses can affect this physiological process resulting in delayed puberty . Delayed puberty is defined as the lack of pubertal signs until the age of 13 years in girls, and the age of 14 years in boys. Delayed puberty is classified into two categories according to their cause; central gonadotropin deficiency (hypogonadotropic hypogonadism) and this type comprises delayed puberty due to chronic illness, while the second category of delayed puberty is due to gonadal disorders (hypergonadotropic hypogonadism).
Delayed puberty is common among pediatric patients with chronic kidney disease (CKD) - where glomerular filtration rate (GFR) is less than 60 ml/min per 1.73 m2. Previous studies suggested that, the cyclic pattern of GnRH release is lost in patients with CKD resulting in impairment of gonadotropins secretion from the anterior pituitary gland. Multiple hormonal factors had been proposed to be responsible for the pubertal delay in patients with CKD, the most prominent of which is the increasing levels of prolactin, LH and GnRH (4). Prolactin normally inhibits the release of GnRH from hypothalamus thus inhibiting the initiation of puberty and it was found to increase in patients with CKD secondary to increased production, slightly decreased clearance and decreased responsiveness to the hypothalamic inhibition of prolactin secretion.
Furthermore, recent studies reported that the Kisspeptin protein play an important role in the regulation and control of normal puberty, As it was found that the Kisspeptin neurons (the rostral periventricular region of the third ventricle (RP3V) and arcuate nucleus (ARC), are found in close association with the GnRH releasing neurons in the hypothalamus suggesting that these neurons might play a crucial role in activating and restoring the pulsatile release of GnRH, It was also found that inactivating mutations of the gene encoding for kisspeptin were associated with hypogonadotropic hypogonadism.
Conditions
- Evaluation of Some Puberty-related Hormones Among Children and Adolescents With Chronic Kidney Diseases
Interventions
- DIAGNOSTIC_TEST
-
serum kisspeptin levels
Evaluation of the serum level of LH, FSH, prolactin, Testosterone (in boys), estradiol (in girls) and Kisspeptin levels
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 8 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-31
- Primary Completion
- 2024-05-31
- Completion
- 2024-05-31
Countries
- Egypt
Study Locations
More Related Trials
-
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
NCT00493961 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney Disease
NCT00194961 ·Status: TERMINATED ·Phase: PHASE4
-
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)
NCT00392756 ·Status: COMPLETED ·Phase: PHASE1
-
National Cooperative Growth Study in CKD
NCT00616278 ·Status: COMPLETED
-
Effect of Cytokines on Growth of Children With Chronic Kidney Failure
NCT00194883 ·Status: SUSPENDED ·Phase: PHASE4
-
A Study in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD)
NCT00097617 ·Status: COMPLETED
-
Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing
NCT00324064 ·Status: COMPLETED ·Phase: NA
-
Growth Hormone in EB
NCT05390073 ·Status: UNKNOWN
-
Effect of Exogenous Growth Hormone on Ocular Findings
NCT05338411 ·Status: UNKNOWN
-
Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.
NCT00184769 ·Status: COMPLETED ·Phase: PHASE4
-
Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease
NCT00184652 ·Status: COMPLETED ·Phase: PHASE2
-
Endocrine Studies of Healthy Children
NCT00001195 ·Status: COMPLETED
-
Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism
NCT04648969 ·Status: COMPLETED ·Phase: PHASE2
-
Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism
NCT02880280 ·Status: UNKNOWN ·Phase: PHASE4
-
Diagnosing Adult Growth Hormone Deficiency
NCT03018886 ·Status: COMPLETED ·Phase: NA
-
Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders
NCT01165619 ·Status: TERMINATED
-
Impact of GH Measurements on GHD Diagnosis
NCT04508673 ·Status: COMPLETED
-
Growth Hormone For Poor Ovarian Reserve Patients in ICSI Trials
NCT05602090 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Link Between the Sensitivity of Kisspeptin Signalling and Pubertal Onset in Boys.
NCT03286517 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Prospective Study on Patients Treated With Norditropin®
NCT00960128 ·Status: COMPLETED
-
Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function
NCT03186495 ·Status: COMPLETED ·Phase: PHASE1
-
Growth Hormone and Endothelial Function in Children
NCT00373386 ·Status: COMPLETED ·Phase: PHASE4
-
Triptorelin for Early Diagnosis of Hypogonadotrophic Hypogonadism
NCT06691815 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
NCT03249480 ·Status: UNKNOWN ·Phase: PHASE4
-
Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
NCT01604395 ·Status: RECRUITING